PORTAL VEIN THROMBOSIS
Clinical trials for PORTAL VEIN THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new PORTAL VEIN THROMBOSIS trials appear
Sign up with your email to follow new studies for PORTAL VEIN THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough liver cancers
Disease control CompletedThis study tested a new treatment for advanced liver cancer that has spread into the main blood vessels of the liver. 63 patients received precise proton beam radiation followed by a combination of two drugs (Tecentriq and Avastin) to boost the immune system and block tumor blood…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
Triple-drug attack shows promise against tough liver cancer
Disease control CompletedThis study tested a three-drug combination for people with advanced liver cancer that has spread into the portal vein. The treatment adds a direct liver chemo infusion to two standard drugs (lenvatinib and a PD-1 inhibitor). 66 patients took part to see if the triple therapy work…
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
Stent opens blocked vein, eases cancer Patients' symptoms
Disease control CompletedThis study tested a procedure to place a small metal tube (stent) in the portal vein of 63 cancer patients whose vein was blocked by a tumor. The goal was to relieve serious symptoms like fluid buildup in the belly or bleeding in the gut. The procedure was safe and helped improve…
Matched conditions: PORTAL VEIN THROMBOSIS
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Computer model helps cirrhosis patients get right blood thinner dose faster
Knowledge-focused CompletedThis study tested whether a computer program (Simcyp) could help doctors choose the right starting dose of warfarin, a blood thinner, for 21 patients with liver cirrhosis and a blood clot in the portal vein. The goal was to reach a safe and effective level of blood thinning more …
Matched conditions: PORTAL VEIN THROMBOSIS
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC